Does FBRX IV Look Way High to You Also?

Sept @ over 500% just makes no sense to me looking at the chart...what do you guys think here? Not great liquidity but definitely seems like an opportunity for some net credit strategies.

 

Market is totally mispriced. How could a clinical stage biotech with one drug possibly have 500 vol 3 weeks out!

 

So you are sarcastically saying 500% is perfectly reasonable in this situation and these options are not overpriced, got it.

 

Check if there's an FDA announcement due.

 

yep that's it, on the 7th they are releasing data on a phase 2 clinical trial. Market pricing in a big move i suppose.

 

well I bought a reasonable about of gamma, so yes. I think the vol is unreasonable. I think the vol is too cheap.

 

interesting. How did you go about dong that (which long gamma strategy)?

 

Im not comfortable sharing that here. But o believe the vol is cheap.

 

fair enough. Looking forward to seeing what happens.

 

me too.